Zobrazeno 1 - 10
of 111
pro vyhledávání: '"drug-induced acute pancreatitis"'
Publikováno v:
National Board of Examinations Journal of Medical Sciences, Vol Volume 2, Iss Issue 9, Pp 944-949 (2024)
Acute pancreatitis (AP) is an inflammatory condition, characterized by elevated levels of amylase and lipase, with manifestation of acute abdominal pain and acute with high mortality and morbidity rates. The most common causes of AP other than gallbl
Externí odkaz:
https://doaj.org/article/f15b5b4ee099498a9aaa67f05fdb23e5
Autor:
Pugazhendi Inban, Virali Gulla, Aarfa Devani, Chinaza Mercy Akuma, Chengala Ananyaa Gowthavaram, Akbar Hussain, Lynn Lat Lat Aung, Neel Jadav, Bansi Savaliya, Taha Sajjad, Aadil Mahmood Khan, Ogbonnaya Akuma, Anasonye Emmanuel Kelechi
Publikováno v:
Clinical Case Reports, Vol 11, Iss 12, Pp n/a-n/a (2023)
Key Clinical Message Drug‐induced acute pancreatitis is a potentially ignored diagnosis that must be precisely valued. Drug‐induced acute pancreatitis can be considered the third common cause of acute pancreatitis after ruling out alcohol and gal
Externí odkaz:
https://doaj.org/article/aa7094b4070f438991d8213875054228
Publikováno v:
Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-7 (2022)
Abstract Background Unregulated use of a variety of drugs and supplements by bodybuilders and athletes is common and can lead to severe adverse complications. Only a small proportion of acute pancreatitis cases are drug induced, and case reports are
Externí odkaz:
https://doaj.org/article/da2cc1681b0b40a291d2909b54fc3c52
Autor:
Angelo Del Gaudio, Carlo Covello, Federica Di Vincenzo, Sara Sofia De Lucia, Teresa Mezza, Alberto Nicoletti, Valentina Siciliano, Marcello Candelli, Antonio Gasbarrini, Enrico Celestino Nista
Publikováno v:
Antibiotics, Vol 12, Iss 10, p 1495 (2023)
Acute pancreatitis (AP) is an acute inflammation of the pancreas caused by the activation of digestive enzymes in the pancreatic tissue. The main causes of AP are cholelithiasis and alcohol abuse; less commonly, it can be caused by drugs, with a prev
Externí odkaz:
https://doaj.org/article/d8ccbbc1175047d39552fb7549ff0eb6
Autor:
Daniel Paramythiotis, Eleni Karlafti, Kalliopi Veroplidou, Maria Fafouti, Georgia Kaiafa, Smaro Netta, Antonios Michalopoulos, Christos Savopoulos
Publikováno v:
Diagnostics, Vol 13, Iss 8, p 1398 (2023)
Coronavirus disease-19 (COVID-19), caused by SARS-CoV-2, is a systemic disease that affects not only the respiratory system, but also other systems, including gastrointestinal. A great number of different drugs have been used on hospitalized patients
Externí odkaz:
https://doaj.org/article/d1dd4a844a0548f89a81030ea385146d
Publikováno v:
Pharmacy, Vol 10, Iss 6, p 144 (2022)
We describe the risk factors for the development, timing, and severity of doxycycline induced acute pancreatitis (DIAP) in two case reports and a review of prior published cases, to better understand DIAP. Clinicians must maintain a high level of sus
Externí odkaz:
https://doaj.org/article/577ee447056b45a8918c4b18e2d365fd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Siberian Medical Review. :35-43
Drug-induced (DI) acute pancreatitis (AP) is a difficultly diagnosed disease amounting to 2% among all AP cases that may lead to development of life-threatening complications. This article considers potentially hazardous medicinal products as well as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97e403860d85331058c9c650509e8160
https://doi.org/10.20333/25000136-2021-3-35-43
https://doi.org/10.20333/25000136-2021-3-35-43
Autor:
Kazumichi Kawakubo, Hiroo Hata, Hiroshi Kawakami, Masaki Kuwatani, Shuhei Kawahata, Kimitoshi Kubo, Keisuke Imafuku, Shinya Kitamura, Naoya Sakamoto
Publikováno v:
Case Reports in Oncology, Vol 8, Iss 2, Pp 356-358 (2015)
Pazopanib is an oral angiogenesis inhibitor targeting vascular endothelial growth factor receptors, platelet-derived growth factor receptors, and c-Kit approved for the treatment of renal cell carcinoma and soft tissue sarcoma. Nonselective kinase in
Externí odkaz:
https://doaj.org/article/7fdec6f2841449c58517df1326abcac1